Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Background:
This is a randomized controlled trial (RCT) of two novel behavioral interventions to enhance treatment adherence and improve low-density lipoprotein cholesterol (LDL) in diabetes. Among adults with diabetes, high LDL greatly increases their risk for cardiovascular disease (CVD). Despite the proven efficacy of LDL control(<100 mg/dL) in preventing CVD, the control rate is low. Poor adherence to treatment(diet, exercise and medication) is the main reason for this poor control.
Aims: This study will test two telephone-delivered interventions, a Transtheoretical stage-matched intervention (SMI) and a Prospect theory-based framing effects intervention (FEI). The investigators hypothesize that both SMI and FEI will be more effective in improving LDL control than an attention placebo intervention (API) at 6 months. SMI and FEI will also be more effective in increasing adherence to medications, diet and exercise than API at 6 months.
Methods:
The investigators will recruit 246 adults with diabetes and high LDL despite being on medications. Key outcomes are adherence to diet, exercise and medication, and LDL control. The interventions will be standardized and fidelity of intervention maintained. Using a blinded RCT the investigators will test the effect of SMI and FEI compared to API on LDL control and adherence. All analyses will be intent to treat.
Significance:
This project will provide important information to improve diabetes-related behavior and lead to the implementation of novel interventions for lowering LDL in primary care settings among adults with diabetes. It may also provide the scientific rationale to use such approaches to control other risk factors in diabetes.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| stage-matched intervention | Experimental | Transtheoretical Model-based stage-matched intervention |
|
| framing effects intervention | Experimental | counseling based on prospect theory |
|
| attention placebo intervention | Active Comparator | counseling about general health topics |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| stage-matched intervention | Behavioral | 6 monthly tailored telephone-delivered counseling sessions of transtheoretical model-based counseling |
|
| Measure | Description | Time Frame |
|---|---|---|
| LDL control | 6 months | |
| medication adherence | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| diet adherence | 6 months | |
| exercise adherence | 6 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sundar Natarajan, MD, M.Sc. | VA New York Harbor Healthcare System | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| VA New York Harbor Healthcare System, NY and BK Campuses | New York | New York | 10010 | United States |
Not provided
| ID | Term |
|---|---|
| D006937 | Hypercholesterolemia |
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D006949 | Hyperlipidemias |
| D050171 | Dyslipidemias |
| D052439 | Lipid Metabolism Disorders |
| D008659 | Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| framing effects intervention | Behavioral | 6 monthly telephone-delivered counseling sessions based on prospect theory |
|
| attention placebo intervention | Behavioral | 6 monthly counseling sessions about general health topics |
|
| D009750 |
| Nutritional and Metabolic Diseases |
| D044882 | Glucose Metabolism Disorders |
| D004700 | Endocrine System Diseases |